Literature DB >> 27454071

Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other.

D Çağdaş1, B Erman1, D Hanoğlu2, B Tavil3, B Kuşkonmaz3, B Aydın4, C Akyüz4, D Uçkan3, Ö Sanal1, I Tezcan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27454071     DOI： 10.1038/bmt.2016.185

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.

Authors:  R M Linka; S L Risse; K Bienemann; M Werner; Y Linka; F Krux; C Synaeve; R Deenen; S Ginzel; R Dvorsky; M Gombert; A Halenius; R Hartig; M Helminen; A Fischer; P Stepensky; K Vettenranta; K Köhrer; M R Ahmadian; H-J Laws; B Fleckenstein; H Jumaa; S Latour; B Schraven; A Borkhardt
Journal:  Leukemia       Date:  2012-01-06       Impact factor: 11.528

2.  Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.

Authors:  X C Liao; D R Littman
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

3.  IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection.

Authors:  D Mansouri; S A Mahdaviani; S Khalilzadeh; S A Mohajerani; M Hasanzad; S Sadr; S A Nadji; S Karimi; A Droodinia; N Rezaei; R M Linka; K Bienemann; A Borkhardt; M R Masjedi; A A Velayati
Journal:  Int Arch Allergy Immunol       Date:  2012-04-05       Impact factor: 2.749

Review 4.  The role of Tec family kinases in T cell development and function.

Authors:  Julie A Lucas; Andrew T Miller; Luana O Atherly; Leslie J Berg
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

5.  Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.

Authors:  Kirsten Huck; Oliver Feyen; Tim Niehues; Franz Rüschendorf; Norbert Hübner; Hans-Jürgen Laws; Tanja Telieps; Stefan Knapp; Hans-Heinrich Wacker; Alfons Meindl; Hassan Jumaa; Arndt Borkhardt
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

6.  Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

Authors:  R S Shapiro; K McClain; G Frizzera; K J Gajl-Peczalska; J H Kersey; B R Blazar; D C Arthur; D F Patton; J S Greenberg; B Burke
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

7.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

8.  Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Authors:  Andreas Moosmann; Iris Bigalke; Johanna Tischer; Leah Schirrmann; Julitta Kasten; Stefanie Tippmer; Marina Leeping; Dusan Prevalsek; Gundula Jaeger; Georg Ledderose; Josef Mautner; Wolfgang Hammerschmidt; Dolores J Schendel; Hans-Jochem Kolb
Journal:  Blood       Date:  2010-01-26       Impact factor: 22.113

9.  Innate immune control of EBV-infected B cells by invariant natural killer T cells.

Authors:  Brian K Chung; Kevin Tsai; Lenka L Allan; Dong Jun Zheng; Johnny C Nie; Catherine M Biggs; Mohammad R Hasan; Frederick K Kozak; Peter van den Elzen; John J Priatel; Rusung Tan
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

Review 10.  Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects.

Authors:  Sujal Ghosh; Kirsten Bienemann; Kaan Boztug; Arndt Borkhardt
Journal:  J Clin Immunol       Date:  2014-10-24       Impact factor: 8.317
View more
  8 in total

1.  Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.

Authors:  Leila Youssefian; Hassan Vahidnezhad; Mehdi Yousefi; Amir Hossein Saeidian; Arghavan Azizpour; Andrew Touati; Neda Nikbakht; Kambiz Kamyab- Hesari; Mohammad Mahdi Adib-Sereshki; Sirous Zeinali; Behzad Mansoori; Ali Jazayeri; Razieh Karamzadeh; Paolo Fortina; Emmanuelle Jouanguy; Jean-Laurent Casanova; Jouni Uitto
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

2.  A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect.

Authors:  Sahib Rovshanov; Rahşan Göçmen; İbrahim Barişta; Deniz Çağdaş; Ayşegül Üner; Vedat Çilingir; İrsel Tezer Filik; Çağman Tan; Elif Soyak Aytekin; İlhan Tezcan; Pınar Acar Özen; Aslı Tuncer
Journal:  Noro Psikiyatr Ars       Date:  2022-08-15       Impact factor: 1.066

Review 3.  Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes.

Authors:  Christian Münz
Journal:  Front Immunol       Date:  2017-11-24       Impact factor: 7.561

Review 4.  Human immunity against EBV-lessons from the clinic.

Authors:  Stuart G Tangye; Umaimainthan Palendira; Emily S J Edwards
Journal:  J Exp Med       Date:  2017-01-20       Impact factor: 14.307

Review 5.  Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.

Authors:  Sylvain Latour; Sarah Winter
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

6.  Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

Authors:  Nicole Caduff; Donal McHugh; Anita Murer; Patrick Rämer; Ana Raykova; Vanessa Landtwing; Lisa Rieble; Christian W Keller; Michael Prummer; Laurent Hoffmann; Janice K P Lam; Alan K S Chiang; Friedrich Raulf; Tarik Azzi; Christoph Berger; Tina Rubic-Schneider; Elisabetta Traggiai; Jan D Lünemann; Michael Kammüller; Christian Münz
Journal:  PLoS Pathog       Date:  2020-04-06       Impact factor: 6.823

Review 7.  Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?

Authors:  Sujal Ghosh; Ingo Drexler; Sanil Bhatia; Heiko Adler; Andrew R Gennery; Arndt Borkhardt
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

8.  Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.

Authors:  Matthew K Howe; Kennichi Dowdell; Amitava Roy; Julie E Niemela; Wyndham Wilson; Joshua J McElwee; Jason D Hughes; Jeffrey I Cohen
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.